Skip to main content
. 2018 Apr 29;20(4):429–439. doi: 10.1177/1099800418772346

Table 5.

Functional Capacity, Symptoms, and Quality of Life at Baseline and 6 and 12 Months After Cardiopulmonary Rehabilitation in Veterans With HF and COPD, Combined, by Mortality Group.

Variable Time Point Wald χ2 p Value
Baseline (Mean ± SD) 6 Months (Mean ± SD) 12 Months (Mean ± SD) Groupa Group × Timeb Groupa Group × Timeb
Functional capacity
 6MWD (m) 2.36 1.13 .12 .29
  Total 354.69 ± 117.39 343.17 ± 113.89 314.29 ± 131.29
  Alive at 12 months 367.28 ± 113.48 349.62 ± 131.62 314.29 ± 131.29
  Dead at 12 months 225.70 ± 73.13 192.63 ± 110.74
 Total steps/24 hr 1.37 0.89 .24 .34
  Total 5,337.27 ± 3,053.33 5,244.92 ± 3,120.10 5,327.00 ± 3,324.02
  Alive at 12 months 5,551.47 ± 3,077.57 5,327.79 ± 3,154.98 5,327.00 ± 3,324.02
  Dead at 12 months 3,141.74 ± 1,699.58 3,558.53 ± 611.42
Symptoms
 COPD Dyspnea Scale 3.99 0.76 .04 .38
  Total 3.02 ± 1.40 2.69 ± 1.36 2.85 ± 1.58
  Alive at 12 months 2.90 ± 1.38 2.67 ± 1.32 2.85 ± 1.58
  Dead at 12 months 4.25 ± 0.93 3.17 ± 2.27
Quality of life
 SF-36 V, PCS 0.29 0.54 .59 .46
  Total 31.96 ± 8.19 32.83 ± 10.27 32.02 ± 10.99
  Alive at 12 months 32.63 ± 7.95 33.35 ± 10.06 32.02 ± 10.99
  Dead at 12 months 25.12 ± 7.84 19.96 ± 7.56
 SF-36 V, MCS 5.92 11.84 .02 .001
  Total 48.84 ± 11.81 51.47 ± 11.67 50.04 ± 11.53
  Alive at 12 months 49.11 ± 12.06 51.20 ± 11.81 50.04 ± 11.53
  Dead at 12 months 46.06 ± 9.08 58.05 ± 3.46
 SF-36 V, physical function 5.04 1.08 .025 .29
  Total 38.63 ± 20.68 43.53 ± 23.55 41.76 ± 25.00
  Alive at 12 months 40.27 ± 20.70 44.67 ± 22.90 41.76 ± 25.00
  Dead at 12 months 21.85 ± 11.31 15.00 ± 25.98
 SF-36 V, general health 0.33 2.33 .57 .12
  Total 46.69 ± 18.41 48.67 ± 20.88 48.89 ± 20.58
  Alive at 12 months 48.44 ± 17.85 50.16 ± 19.72 48.89 ± 20.58
  Dead at 12 months 28.50 ± 14.82 11.67 ± 16.07
Cardiopulmonary function
 FEV1 4.65 2.23 .03 .14
  Total 39.85 ± 19.20 41.82 ± 22.35 44.62 ± 20.87
  Alive at 12 months 40.83 ± 19.58 42.49 ± 22.49 44.62 ± 20.87
  Dead at 12 months 29.75 ± 11.18 25.50 ± 3.53
 NT-proBNP 1.15 2.79 .28 .09
  Total 1,086.28 ± 2,013.60 727.10 ± 2,013.60 708.86 ± 1,124.69
  Alive at 12 months 985.93 ± 1,913.75 722.55 ± 968.84 708.86 ± 1,124.69
  Dead at 12 months 2,114.88 ± 2,800.81 863.50 ± 775.70
Self-efficacy
 Self-efficacy exercise 0.30 0.14 .59 .71
  Total 6.44 ± 2.33 5.63 ± 2.45 5.28 ± 2.89
  Alive at 12 months 6.61 ± 2.24 5.72 ± 2.42 5.28 ± 2.89
  Dead at 12 months 4.67 ± 2.62 3.22 ± 2.14
 Self-efficacy walking 4.02 0.45 .05 .83
  Total 2.82 ± 2.42 3.82 ± 3.08 3.20 ± 2.92
  Alive at 12 months 2.96 ± 2.48 3.92 ± 3.09 3.20 ± 2.92
  Dead at 12 months 1.38 ± .92 1.33 ± 1.53

Note. Total N = 90; alive at 12 months = 82; dead at 12 months = 8. 6MWD = 6-min walk distance; COPD = chronic obstructive pulmonary disease; HF = heart failure; FEV1 = forced expiratory volume in 1 s; MCS = mental component score; NT-proBNP = N-terminal pro-brain natriuretic peptide; PCS = physical component score; SF-36 V = Short-Form 36–Veterans version.

aGroup differences between those who were alive at 12 months compared with those who had died by 12 months. bDead and alive Trajectory × Time.